Epi-Otic Cleanser Drug Information [ Virbac ]
Table of content
Epi-Otic Cleanser category:
Active ingredients:
Epi-Otic Cleanser companies and manufacturers:
General Information
Epi-Otic Cleanser forms, composition and dosages:
- Liquid; Otic; Lactic Acid 2.5%; Salicylic Acid 0.1%
Indications, usages and classification codes:
- D02AF - Salicylic Acid preparations
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
- Anticollosity Ointment Tver Pharmaceutical Factory
- Antiverrugas ISDIN
- Bazuka Dendron; Diomed Developments
- Bruciaporri Giovanardi Farmaceutici del Dr. Benito Giovanardi e Figli
- Calicida Indiano Solution Gestafarma Sociedade Farmaceutica
- Calotrat Kley Hertz
- Caminol Geminis
- Clabin Deutsche Chefaro Pharma
- Cuplex Stiefel Laboratories; Crawford Pharmaceuticals; Smith & Nephew; Trans Canaderm
- Dermatech Wart Treatment Dermatech Laboratories; Sime Darby Marketing
- Duofilm Stiefel Laboratories; Allphar Services; Diethelm; Gabriel Health; Mediner; Qualicare; Sanova Pharma; Schering-Plough
- Duofilm Topical Paint Stiefel Laboratories; David Sparks
- Efasit N Tincture Togal-Werk
- Gehwol Huhneraugen Pflaster Eduard Gerlach
- Kerafilm Pierre Fabre; Ducray Laboratoire
- Kerafilmver Pierre Fabre
- Kinor Siegfried Rhein
- Kroko Aspen Pharmacare
- Kusmin Alcon
- Lactisol Genesis Pharmaceuticals
- Advantage fur Katzen Bayer
- Advantage Multi 100 Bayer
- Advantage Multi 55 Bayer
- Advantage Multi for Dogs Bayer
- Advantage Perros Bayer
- Advantix Bayer; Provet
- Advantix Spot-on Losung fur Hunde Bayer
- Advocate for Dogs Bayer
- Advocate for Dogs 10-25 kg Bayer
- Advocate for Dogs 4-10 kg Bayer
- Advocate for Dogs over 25 kg Bayer
- Advocate for Puppies and Small Dogs up to 4 kg Bayer
- Advocate fur grose Hunde Bayer
- Advocate fur kleine Hunde Bayer
- Advocate fur mittelgrose Hunde Bayer
- Advocate fur sehr grose Hunde Bayer
- Advocate Losung zum Auftropfen fur Hunde Bayer
- AErrane Baxter; AstraZeneca; Ohmeda Pharmaceutical Products; Pfizer
- Agrovet Novartis
- Agrovet PS Novartis